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ABSTRACT 
 
Surgeries performed in retained third molars occur in the contaminated field, bringing post-operative 
problems such as pain, bleeding, discomfort, swelling, infection, trismus, and inactive days. This study 
evaluated the differences between conventional medication and topical doxycycline in third molar surgery. 
Twenty-eight patients were selected requiring removal of four third molar. Half of the mouth was randomly 
selected to undergo surgery with the use of conventional medication (analgesic, anti-inflammatory and 
antimicrobial) and after 25-30 days, the other half of the mouth was subjected to surgery using doxycycline 
delivered through gel nanotubes. The results showed that in both treatments there was no clinical infection. 
The other evaluations were significantly lower in relation to pain, bleeding, edema, inactive days, trismus, and 
discomfort when compared with conventional therapy. 
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INTRODUCTION 
 
Surgeries performed in 
retained third molars occur in the 
contaminated field, bringing post-
operative problems such as pain, 
bleeding, discomfort, swelling, 
infection, trismus, and inactive days 1. 
Combined treatments with non-
steroidal anti-inflammatory drugs and 
antibiotics may offer significant benefits 
in the prevention of pain and infections 
associated with oral surgery 2. However, 
there is no consensus on the use of 
antibiotics to minimize infectious 
complications and despite the increase 
in the rates of bacterial resistance, 
prophylactic use of antibiotics is very 
widespread in this type of surgery 3.  
Incorporating drug-delivery 
platforms into medical devices offers the 
benefits of controlled release and 
localized delivery of drugs, which can 
improve efficacy of treatments for 
dentistry, cardiology, ophthalmology, 
and orthopedic applications, among 
others, minimizing adverse reactions 
and bacterial resistance 4-6. The progress 
in drug-delivery technology has thrust 
degradable platforms into the spotlight 
in recent years, as the key enabler of 
degradable drug-delivery systems, the 
bioabsorbable polymer poly (lactic-co-
glycolic acid) 7, 8. 
Topical antibiotics have 
certain benefits such as high 
concentrations, topical application and 
persistence in place since physiological 
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changes in the region may compromise 
the efficacy of systemic antibiotics 7. 
Another very important 
advantage is the low systemic absorption 
and low toxicity, which consequently 
reduces the intake of systemic 
antibiotics and, invariably, the 
possibility of developing a systemic side 
effect 9. 
 In 1985, tetracyclines were 
discovered to have anticollagenolytic 
activity and were proposed as a host-
modulating agent. Initial studies 
demonstrated that doxycycline was the 
most potent tetracycline in the 
inhibition of colagenollytic activities 10. 
 Accumulating evidence 
suggests that activation of proteolytic 
enzymes, including the matrix 
metalloproteinase family, is responsible 
for the collagen destruction during 
inflammatory diseases 11. Apparently, an 
imbalance between activation of matrix 
metalloproteinase and down regulation 
of their endogenous inhibitors leads to 
pathologic breakdown of the 
extracellular matrix 11. 
Tetracyclines have long been 
used as adjuncts in the treatment of 
periodontal diseases 11, 12. Although 
initially attributed to its antimicrobial 
properties, the clinical efficacy of 
tetracyclines in periodontitis has been 
recently suggested to be due to their 
intrinsic anti-inflammatory activity, 
since low doses (subantimicrobial) of 
doxycycline decrease attachment loss 
and excessive collagense activity in the 
crevicular fluid of periodontitis patients 
11. Considering the anti-inflammatory 
properties of doxycycline, the aim of this 
study was to evaluate the differences 
between conventional medication and 
topical doxycycline delivered through gel 
nanotubes in the postoperative of  
retained third molar surgery class II.  
MATERIALS AND METHODS 
  
 A split-mouth prospective 
clinical trial was performed on 28 
patients requiring class II removal of 
four third molars in the Dental Hospital 
of Uberlândia Federal University, Minas 
Gerais, Brazil, to evaluate the occurrence 
of pain, bleeding, discomfort, swelling, 
infection, trismus, and inactive days 
during the postoperative period. The 
patient received explanations on how to 
identify each of these signs and 
symptoms. The discomfort was seen 
when there was a feeling of heaviness in 
the side where the surgery was 
performed and the infection would be 
investigated if there was purulent 
discharge in the suture site. The 
surgeries were performed, randomly, by 
three surgeons dentists, residents of the 
residency program in oral and 
maxillofacial surgery and traumatology, 
which also contributed to the objectives 
and design of this study. The patients 
agreed with the research and signed an 
informed consent form, according to the 
protocol 274/2011 of the Ethics 
Committee for Human Research of 
Uberlândia Federal University, which 
could be provided upon request. This 
commitee approved the study, in 
accordance with the ethical standards 
laid down in the 1964 Declaration of 
Helsinki and its later amendments. Half 
of each patient’s mouth was randomly 
selected to undergo surgery and used 
conventional medication according to 
the residency program protocol for 
dental surgery (analgesic - Dipyrone 
Sodium 500 mg every six hours while 
there is pain; anti-inflammatory - 
Diclofenac Sodium 50 mg every eight 
hours for five days and antimicrobial - 
Amoxicillin 4g one hour before the 
surgical procedure and 500 mg every 
eight hours, for seven days) and this, was 
considered the control situation 13-15. 
After 25 to 30 days, the other half of the 
mouth was subjected to surgery using 
10mg doxycycline (Pharma Nostra, 
Anápolis, Goiás, Brazil) gel (HPMC - 
hydroxypropyl methylcellulose) handled 
and packaged aseptically in a laboratory, 
under license from national health 
surveillance agency - ANVISA No. 28023) 
delivered through gel nanotubes, after 
the toilet of surgical site and prior to 
suture, and this situation being 
considered experimental; on both sides, 
an ostectomy was necessary. 
Doxycycline was used only when the 
patient returned to perform the surgery 
in the other half of the mouth. No other 
antibiotics or anti-inflammatories were 
used concomitantly with the use of 
doxcicicline. At the time of removal of 
sutures, the patients assigned grades 
from zero to ten, with zero being the 
absence of signs or symptoms. At the end 
of the study, the mean score for the 
controls was compared with the cases.  
 
STATISTICAL ANALYSIS 
 
The t test was performed 
comparing the scores given by patients 
after the use of conventional medication 
and after topical doxycycline delivered 
through gel nanotubes. P ≤ 0.05 was 
considered statistically significant. 
 
RESULTS 
 
A total of 110 surgeries were 
performed, 55 experimental and 55 
controls, since in one patient were only 
two. The results showed that, in both 
treatments, there was no clinical 
infection. The other evaluations were 
36.36% (P = 0.01), 46.55% (P = 0.04), 58.62% 
(P < 0.0001), 70.91% (P < 0.0001), 71.72% 
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(P < 0.0001) and 69.49% (P < 0.0001) 
lower in relation to pain, bleeding, 
edema, inactive days, trismus, and 
discomfort, respectively, when 
compared with conventional therapy 
(Table 1). Regarding the evaluation of 
pain, five patients who used doxycycline 
reported the need to take a single dose of 
dipyrone after the end of the anesthetic 
effect.  
 
DISCUSSION 
 
In infectious processes, 
microorganisms take the host cells to 
produce pro-inflammatory cytokines 
which may induce destructive processes 
that attack the soft and/or hard tissues of 
the oral cavity leading to tissue damage 
and the onset of the disease 16, 17. In our 
study there was no clinical infection in 
both treatments. 
Patients often suffer 
considerable post-operative pain, 
hyperemia, bleeding, edema, trismus, 
and discomfort 18. Sub-antimicrobial 
dose doxycycline aims to modulate the 
host by suppressing the inflammatory 
response 11. Additionally, it has long been 
known that members of the tetracycline 
family possess the ability to inhibit 
matrix metalloproteinases, 
independently of their antimicrobial 
activities matrix metalloproteinases, 
many of which are produced by 
infiltrating neutrophils, mediate this 
tissue destruction by degrading plasma 
membrane proteins and extracellular 
matrix proteins such as collagen 1. In our 
study pain, bleeding, edema, trismus, 
and discomfort were significantly lower 
when using the doxycycline gel in 
nanotubes, compared with conventional 
treatment, which resulted in a reduction 
in the number of inactive days and 
treatment costs. Also, patient 
compliance to treatment was increased. 
For several reasons, this evaluation of the 
signs and symptoms after surgery was 
made by patients, previously trained, 
including the high demand for dental 
care in the hospital, which would 
compromise the care of patients not 
involved in the research, to avoid that 
patients had to travel to the hospital, 
since there was a need for rest, and 
because we consider that there would be 
greater fidelity to evaluate the intensity 
of symptoms. However, the intensity of 
some signals could be better assessed by 
a trained professional. 
The statistically better results 
for the experimental group can be 
justified by the fact doxycycline, 
inoculated into the surgical cavity prior 
to closure, is inserted in a degradable 
platform which allows controlled and 
extended release of the drug in a 
therapeutically relevant concentration. 
Other benefits include increased 
bioavailability, improved patient 
compliance, higher efficiency, low side 
effects, limited potential for systemic 
absorption and toxicity, reduced 
volumes of antibiotic use, and, possibly, 
less potential for the development of 
antibiotic resistance, e.g. bowel 
microbiota 6. 
 
CONCLUSION 
 
We conclude that the use of 
doxycycline gel in nanotubes was more 
effective in reducing postoperative signs 
and symptoms, as well as post-surgical 
comfort and adherence to therapy, does 
not interfere with the normal microbiota 
of the patient, and provides a 
considerable reduction in treatment 
costs 6. Thus, it is possible  to consider 
doxycycline gel in nanotubes an 
alternative medication to modulate the 
inflammatory response in retained third 
molar surgery class II and other dental 
surgical procedures. However, the 
sample size is not enough to ensure the 
power of the study and sophisticated 
tools are needed to examine some of 
these findings, and not all the different 
crystalline forms of a drug will behave 
the same way in terms of their activity 
rate. 
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